Details of the Drug-Related molecule(s) Interaction Atlas

936563-93-8 Drug Info

SCHEMBL793463; SCHEMBL793304; SCHEMBL201745; SCHEMBL460731; SCHEMBL201744; CHEMBL3647967; CHEMBL3912266; BDBM97672; BDBM191614; 936563-93-8; US9181263, 10; US8476284, 40; 2-PropenaMide,N-[cis-4-[4-aMino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyriMidin-1-yl]cyclohexyl];

Cross-matching ID

PubChem CID

24821881

TTD Drug ID

DMPQ2L9

General Information of Drug (ID: DMPQ2L9)

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Investigative Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting Tyrosine-protein kinase CSK (CSK)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
NG-25	DMC48D9	Discovery agent	N.A.	Investigative	[2]
------------------------------------------------------------------------------------

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Tyrosine-protein kinase CSK (CSK)	TTX6F0Q	CSK_HUMAN	Inhibitor	[1]

------------------------------------------------------------------------------------

References

1	Inhibitors of bruton's tyrosine kinase for the treatment of solid tumors. US9278100.
2	Discovery of type II inhibitors of TGFbeta-activated kinase 1 (TAK1) and mitogen-activated protein kinase kinase kinase kinase 2 (MAP4K2). J Med Chem. 2015 Jan 8;58(1):183-96.